Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 249-044-4 | CAS number: 28472-97-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Justification for grouping of substances and read-across
There are only limited data available on the genetic toxicity of diisodecyl azelate (CAS 28472-97-1). In order to fulfil the standard information requirements set out in Annex VII and VIII, 8.4, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006, read-across from structurally related substances was conducted.
In accordance with Article 13 (1) of Regulation (EC) No 1907/2006, "information on intrinsic properties of substances may be generated by means other than tests, provided that the conditions set out in Annex XI are met.” In particular for human toxicity, information shall be generated whenever possible by means other than vertebrate animal tests, which includes the use of information from structurally related substances (grouping or read-across).
Having regard to the general rules for grouping of substances and read-across approach laid down in Annex XI, Item 1.5, of Regulation (EC) No 1907/2006 whereby substances may be predicted as similar provided that their physicochemical, toxicological and ecotoxicological properties are likely to be similar or follow a regular pattern as a result of structural similarity.
Overview of genetic toxicity
CAS |
Chemical name |
Molecular weight (range) |
Genetic toxicity (mutagenicity) in vitro, bacteria |
Genetic toxicity (cytogenicity) in vitro, mammalian cells |
Genetic toxicity (mutagenicity) in vitro, mammalian cells |
Genetic toxicity in vivo |
28472-97-1 (a) |
Diisodecyl azelate |
468.75 |
RA: CAS 103-24-2
|
RA: CAS 103-24-2 |
Experimental result: |
-- |
103-24-2 |
Bis(2-ethylhexyl) azelate |
412.65 |
Experimental result: |
Experimental result: |
-- |
-- |
(a) The substance subject to registration is indicated in bold font.
(b) Reference (read-across) substances are indicated in normal font. Lack of data for a given endpoint is indicated by “--“.
The above mentioned substances are considered to be similar on the basis of the structural similar properties and/or activities. The available endpoint information is used to predict the same endpoints for diisodecyl azelate (CAS 28472-97-1). A detailed analogue approach justification is provided in the technical dossier (see IUCLID Section 13).
Discussion
Gene mutation in bacteria in vitro
Diester of azelaic acid
CAS 103-24-2
The potential mutagenicity of bis(2-ethylhexyl) azelate (CAS 103-24-2) was tested in a bacterial gene mutation assay (Ames test) according to OECD 471 and in compliance with GLP (Miwa, 2004). Based on the results of a preliminary cytotoxicity experiment, the Salmonella typhimurium strains TA 98, TA 100, TA 1535 and TA 1537 and Escherichia coli WP2 uvrA were treated with the test substance at concentrations of 312.5, 625, 1250, 2500 and 5000 µg/plate using the plate incorporation assay. The test was performed in two independent experiments, both with and without metabolic activation system (S9-mix). No cytotoxicity was observed in the two experiments up to the limit concentration of 5000 µg/plate. Colourless oil drop-like and oil membrane-like precipitations were observed on the surface of agar at all test concentrations. The mean number of revertant colonies was not increased at any test concentration compared to control. The positive controls included showed the expected results.
Under the conditions of this experiment, bis(2-ethylhexyl) azelate did not induce mutations in the bacterial gene mutation assay in the selected strains of S. typhimurium (TA 98, TA 100, TA 1535 and TA 1537) and in E. coli WP2 uvrA in the presence and absence of metabolic activation.
Cytogenicity in vitro
Diester of azelaic acid
CAS 103-24-2
The clastogenic potential of bis(2-ethylhexyl) azelate (CAS 103-24-2) was assessed in an in vitro mammalian chromosome aberration test in Chinese hamster lung (CHL/IU) cells according to OECD guideline 473 and under GLP conditions (Miwa, 2004). In a preliminary cytotoxicity test, 50% growth inhibition was observed after 6 h short-term treatment with the test substance at concentrations of 1859.0 µg/mL with S9 mix and at 1555.5 µg/mL without S9 mix. After continuous treatment for 24 h, cell growth was inhibited by 50% at 534.2 µg/mL without S9 mix. Based on these results, concentrations ranging from 150 to 2400 µg/mL (with and without S9 mix) and 37.5 to 600 µg/mL (without S9 mix) were selected for chromosome analysis after 6 and 24 h treatment in the main study, respectively. No increase in the number of cells with chromosomal aberrations was observed compared to controls in any of the experiments performed. The test substance was cytotoxic at ≥ 600 µg/mL after 6 h short-term treatment and at ≥ 300 µg/mL after 24 h continuous treatment. Visible precipitation of the test substance was observed at concentrations ≥ 1200 µg/mL, but did not interfere with chromosomal analysis. The positive controls included during short-term and continuous exposure showed the expected results and thus verified the sensitivity of the assay.
Under the conditions of this experiment, bis(2-ethylhexyl) azelate was considered not to be clastogenic in Chinese hamster lung (CHL/IU) cells in the presence or absence of metabolic activation.
Gene mutation in mammalian cells in vitro
An in vitro mammalian cell gene mutation assay was performed with diisodecyl azelate (CAS No. 28472-97-1) according to OECD guideline 476 (Verspeek, 2010). Mouse lymphoma L5178Y were treated with the test substance diluted in ethanol at concentrations of 0.03, 0.1, 0.3, 1, 3, 10, 33 and 100 µg/mL in cell culture medium with and without S9 mix. Due to solubility of the test substance no higher concentrations had been tested. After treatment the cells were incubated in selective medium with 5 µg/mL trifluorothymidine (TFT) to determine the mutation frequency. No cytotoxicity was observed in range finding tests or the main mutation experiment. The mutation frequency of the treated cultures was in range of historical control data and did not increase at the various concentrations compared to the negative control. Therefore diisodecyl azelate (CAS No. 28472-97-1) did not induce gene mutations in the mouse lymphoma cell line L5178Y at the given test conditions.
Conclusions for genetic toxicity
The available data on diisodecyl azelate (CAS 28472-97-1) and the structurally related substance bis(2-ethylhexyl) azelate (CAS 103-24-2) showed that the results of all in vitro genetic toxicity studies performed in bacteria and mammalian cells with and without metabolic activation were negative.
Justification for selection of genetic toxicity endpoint
Hazard assessment is conducted by means of read-across from structural analogues. No study was selected, since all available in vitro genetic toxicity studies were negative. All available studies are adequate and reliable based on the identified similarities in structure and intrinsic properties between source and target substances and overall quality assessment (refer to the endpoint discussion for further details).
Short description of key information:
Diisodecyl azelate (CAS 28472-97-1) did not induce gene mutations in an in vitro mammalian cell gene mutation test in mouse lymphoma cells.
The read across substances Bis(2-ethylhexyl) azelate (CAS 103-24-2) showed no genotoxic effects, neither in an Ames test nor in a chromosome aberration test.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on substance-specific data and read-across from the structurally similar substance, the available data on genetic toxicity do not meet the classification criteria according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.